Vaxil Bio Is A Cutting Edge Israeli Biotech Focused On Immuno Oncology As Innovative Cancer Treatments Vaxil S Lead Productimmucinhas Recently Been Grantedorphan Drug Status Aefrom Both The Fda And The Ema Agenciesvaxil Is Based Out Of The Weizmann Science Parkisrael S Top Scientific Institutionand Was Founded By Weizmann Phd Drlior Carmon The Company Has Completed A Highly Successful Phase I Ii In 15 Mutiple Myeloma Patientswherein 100Demonstrated Robust Immune Responsesthe Results Of Which Were Published In The British Journal Of Haematology Vaxil S Patented Platformvaxhitwill Protect The Company S Ability To Develop Further Cancer Immunotherapy Products Utilizing The Signal Peptide Domain Of Muc1 Which Is Present In 90Of Cancers Please Visit Www Vaxil Bio Com For More Information
No conferences found for this company.
| Company Name | Vaxil Biotherapeutics Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
